Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
GLYCAR T cells for Liver Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial enrolls patients with a type of cancer that arises from the liver and has come back after standard treatment, has spread outside of the liver, or the patient cannot receive standard treatment. This research study uses special immune system cells called GLYCAR T cells, a new experimental treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service